Grant RadarWorldwide funding
Log inGet started
Back to Grants
Health Open for ApplicationsPAR-25-074

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

National Institutes of Health opportunity PAR-25-074

Eligible Applicants
Organization Types
UniversitiesNGOsSMEsGovernment Agencies
Eligible Countries / Regions
United States
Keywords
National Institutes of HealthPAR-25-074Grants.gov
Related Grants
HealthUpcoming
NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)
Varies
HealthUpcoming
Single Source: Coordinating Center (CC) for the Small Cell Lung Cancer (SCLC) Consortium (U24 Clinical Trial Not Allowed)
Varies
Health● Open
Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed)
Varies
07 May 2027(217d)
Health● Open
DOW Combat Readiness – Medical Research Program Translational Research Award
Varies
18 Nov 2026(47d)
Funding Amount
Varies
USD
Application Deadline
14 October 2026
12 days remaining
Opens: 15 Oct 2024
Apply Now
Programme Details
Programme Code
PAR-25-074